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ABSTRACT
Background: Anomalous coronary artery from the
pulmonary artery (ACAPA) is a very rare congenital
anomaly that often occurs during infancy. Patients can
present in a critical condition.
Methods: We analysed procedure-related data from a
national audit database for the period 2000–2013.
Results: A total of 120 patients <1 year had repair of
isolated ACAPA using a coronary transfer or the tunnel
(Takeuchi) operation. Seven patients (6.8%) required a
mitral valve procedure at index and eight patients
(7.8%) had a mitral valve repair/replacement during
follow-up, including mitral reoperations. Follow-up data
(>30 days) were available in 102 patients and the mean
follow-up time was 4.7 years. The 30-day overall
mortality was 1.9%, higher for neonates (16.7% vs
1%, p=0.1) and after postoperative extracorporeal
membrane oxygenation (ECMO) (20% vs 1%, p=0.09).
At 10 years the survival estimate is 95.1%, freedom
from coronary and mitral reintervention being 95.9%
and 91.2%, respectively. Use of postoperative ECMO
was a risk factor for long-term mortality (p<0.001).
Risk factors for coronary reintervention were age under
30 days (p=0.06) and the need for postoperative ECMO
(p=0.02). Age under 30 days (p=0.002) was a risk
factor for mitral reintervention.
Conclusions: To our knowledge this is the largest
series to date. These preliminary national results show
that early outcomes are good and medium-term
attrition acceptable. Poor outcomes are correlated with
early presentation, also with the need for postoperative
circulatory support.
INTRODUCTION
Anomalous origin of the coronary artery
from the pulmonary artery (ACAPA) is a
very rare anomaly which usually occurs in
isolation. ACAPA can be classiﬁed in infant
ACAPA and non-infant (adult) ACAPA.
They have a different clinical presentation
KEY QUESTIONS
What is already known about this subject?
▸ Anomalous coronary from the pulmonary artery
(ACAPA) is a rare anomaly which usually presents
in infancy with ischaemic cardiomyopathy. This
may result in heart failure and various degrees of
mitral regurgitation. Current treatment options
include establishment of a dual coronary artery
system using typically direct coronary transfer
from the aorta to the pulmonary artery. On small
series, the early and long-term outcomes are excel-
lent. Decreased left ventricular function and young
age at operation are the most common known risk
factors for poor outcomes. Following repair, most
studies report an improvement in myocardial func-
tion followed by resolution in most cases of the
functional mitral regurgitation. Timing of mitral
valve repair/replacement remains a controversy;
however, most authors agree about repairing struc-
tural defects at the time of ACAPA surgery while
functional mitral regurgitation is not addressed.
What does this study add?
▸ This study reports early and medium-term out-
comes following repair of ACAPA in the largest
cohort to date.
▸ ACAPA repair is infrequent in individual centres
due to the rarity of this condition, nevertheless
the results are excellent.
▸ Coronary reinterventions are infrequent and they
all occurred in the first year of follow-up.
▸ Age below 30 days was a risk factor for coronary
and mitral reintervention while use of post-
operative extracorporeal membrane oxygenation
negatively influenced coronary reintervention
and long-term survival.
How might this impact on clinical practice
▸ ACAPA repair is achieved with uniformly good
outcomes.
▸ Monitoring for myocardial ischaemia is war-
ranted during early and medium follow-up.
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and mechanism of disease. In infancy, the vast majority
of patients present with the anomalous left coronary
artery from the pulmonary artery (ALCAPA) rather
than the right coronary connection (ARCAPA).1 Severe
forms of ARCAPA are usually associated with right cor-
onary dominance.1 Some infants develop ischaemic
cardiomyopathy, resulting in left ventricular (LV)
failure and various degrees of mitral regurgitation. A
small number of patients do survive until childhood or
adulthood untreated, due to secondary coronary
collateralisation.2
Both infant and adult ACAPA variants need urgent sur-
gical repair. Reported short and long-term results vary,
depending on centre experience, patient characteristics
and technique used.2–5 The aim of this multicenter
study is to report outcomes following the repair of infant
anomalous coronary artery from the pulmonary artery
using coronary transfer or the tunnel operation in con-
secutive patients treated nationally.
PATIENTS AND METHODS
The data set
The National Institute for Cardiovascular Outcomes
Research (NICOR) collects validated key data on
cardiac procedures from all the UK heart units with the
aim of providing information on surgical and catheter-
based procedures and outcomes. The data is stored in
the Central Cardiac Audit Database (CCAD). NICOR’s
mechanism for congenital data capture, cleaning and
validation is similar to other databases adopted for
adult cardiac surgery.6 Using linkage with census
records at the Ofﬁce of National Statistics, the audit
database publicly reports survival rates at 30 days and
1 year following the index procedure online (available
at: https://nicor4.nicor.org.uk/). This data is periodic-
ally audited, both internally in each centre and also
externally by NICOR. Linkage with survival registries of
Northern Ireland and Scotland cannot be carried out
consistently with their personal identiﬁcation number,
while a minority of patients either have errors in their
social data or are foreign. This resulted in 15% of
patients not having follow data beyond 30 days.
Indications for each operation were given by the multi-
disciplinary teams at each centre. Additional diagnoses
are as selected by the reporting clinicians and concord-
ance between diagnoses and procedures performed are
actively audited. The data quality index for key proced-
ure ﬁelds is above 95%. The need for patient-level
consent to participate in this retrospective study was
waived by the NICOR Research Board. Diagnosis and
procedure codes from the European Pediatric Cardiac
Code Short List are used. A total of 19 (15.4%) patients
were reported to have either LV failure or cardiomyop-
athy, but since there are no guidelines for reporting LV
function to NICOR we believe that this ﬁgure is an
underestimation. We did not use these data in the
analysis.
Patient selection
All data available on the patients undergoing a coronary
artery procedure for a congenital cause between 2000
and 2013 were selected and anonymised. A total of 249
patients of all ages with either an ‘ACAPA diagnosis’ or
an ‘ACAPA repair procedure’ were identiﬁed in the
NICOR data set, which does not differentiate between
the types of ACAPA repair procedures (ie, tunnelling or
reimplantation). Out of these, 214 had an ACAPA
repair, 128 of them being infants; 75 patients older than
1 year were excluded, as were 11 patients with an
undocumented age, due to administrative errors. Since
the objective of the study was to report the results in
patients having ACAPA as their primary defect, we
excluded four infants with complex abnormalities (one
with partially anomalous pulmonary venous connections,
one with atrioventricular septal defect and two with
double-outlet right ventricle) and one patient with
severe aortic valve disease requiring a Ross operation at
index. We also excluded the three infants who were
listed as having a coronary artery bypass grafting
(CABG) procedure. Patient inclusion/exclusion details
can be found in ﬁgure 1.
Statistical analysis
Frequencies are given as absolute numbers and percen-
tages, continuous values as mean (SD) or median (IQR).
Short-term mortality is reported based on 30-day life status
(where follow-up is available). Comparisons of proportions
were carried out with the Fisher Exact test. Estimates of
long-term survival and freedom from reintervention were
evaluated with the Kaplan-Meier method using mortality
(all cause) and reoperations (coronary/mitral valve/pul-
monary) as failure events. Owing to the low number of
death events, we also used a competing risks method and
this resulted in similar results to the Kaplan-Meier
method.7 For brevity, only the results from the actuarial
methods were reported. Predictor variables for short-term
mortality were tested using the χ2 test. For long-term sur-
vival and freedom from reintervention we performed uni-
variable analysis using the log-rank test and Cox
proportional hazards regression (in the case of the mitral
valve reintervention where more than 10 events were avail-
able). The low number of events did not permit a multi-
variable analysis, as to avoid over-parameterisation.
Considered predictor variables for univariable analysis
were: age (continuous), age (under and over 30 days),
extracorporeal membrane oxygenation (ECMO), mitral
valve disease and mitral valve procedure at index.
Population characteristics were compared using the
Mann-Whitney U test, t test and the χ2 test as appropriate.
Statistical analyses were carried out with STATA/IC 11.2
(StataCorp LP, College Station, Texas, USA).
RESULTS
In total 120 infant patients with ACAPA and a coronary
transfer or tunnel operation were identiﬁed, 102 (85%)
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having follow-up extending over 30 days. A detailed
patient inclusion/exclusion ﬂow chart can be seen in
ﬁgure 1. Note that there were no early deaths in the
group of patients excluded due to age (n=86), and two
late deaths, comparable to the retained group.
Short-term mortality/reintervention and long-term
results data are calculated using the group of patients
with >30 days of follow-up (n=102), while all results con-
cerning the index procedure are calculated based on
the whole group of 120 infants, as this data is complete
and shows the status of each patient at the moment of
the operation.
Patient demographic, clinical and procedure-related
data are presented in table 1. Mitral valve regurgitation
was the main associated pathology present at index or
during follow-up in close to 20% of the patients.
A summary of other miscellaneous associated malforma-
tions and procedures can be seen in table 2.
A total of 13 centres performed ACAPA repair for
infants in our time frame, with a patient volume median
of 1.16 patients/year (ranging from a minimum of 0.08
patients/year to a maximum of 3 patients/year). No sig-
niﬁcant differences in outcomes were found between
centres or based on patient volume.
Short-term results
The short-term (30 day) mortality for patients with
follow-up after discharge (n=102) was 1.9% (two patients
died before 30 days), higher for neonates (16.7% vs 1%,
p=0.1) and in patients who required postoperative
ECMO after the repair (20% vs 1%, p=0.09). One
patient was recorded with myocardial infarction (MI) at
presentation and two had a postprocedural MI, although
the criteria used for MI diagnosis and reporting to
NICOR are not documented. One of these patients, a
4-month-old infant, suffered an MI early after the
Table 1 Patient and procedure-related data in patients
with ACAPA
Demographic and follow-up data
Patients (n) 120
Age (days)
Mean (SD) 133 (77)
Median (IQR) 119 (81–168)
Gender (n, %)
Male 76 (63.3%)
Female 44 (36.7%)
Age group (n, %)
Neonate (<30 days) 6 (5%)
Infant (1–12 months) 114 (95%)
Follow-up (y)
Mean (SD) 4.7 (4.1)
Median (IQR) 3.7 (1.2–7.8)
Clinical and procedure-related data
Patients (n) 120
Mitral regurgitation 24 (20%)
Other congenital defects 11 (9.2%)
MVR procedure at index 7 (5.8%)
MVR procedure after index 8 (6.6%)
ECMO 5 (4.2%)
Bypass time (min)
Median (IQR) 113 (96–148)
Cross clamp time (min)
Median (IQR) 55 (42–66)
Circulatory arrest during bypass, (n, %) 8 (6.6%)
Arrest time (min)
Median (IQR) 4.5 (2–8.5)
Postop intubation time (hours)
Median (IQR) 4.5 (2–8)
Hospital stay (days)
Median (IQR) 17 (10–26)
ACAPA, anomalous origin of coronary artery from the pulmonary
artery; ECMO, extracorporeal membrane oxygenation; MVR, mitral
valve repair/replacement.
Figure 1 Patient inclusion and exclusion flow chart. ACAPA,
anomalous origin of coronary artery from the pulmonary
artery; CABG, coronary artery bypass grafting.
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ACAPA repair. Shortly after he underwent a right
outﬂow tract balloon dilation and was discharged alive
after 30 days but lost to follow-up. The second patient, a
13 days old neonate, required ECMO after the ACAPA
repair. She suffered an MI in the early postoperative
period and underwent mitral valvuloplasty and an
unknown coronary procedure at 20 days of age and died
at 38 days of age. The other patient who died in our
group, was a 6-month-old infant, with an associated
patent ductus arteriosus that was ligated at the time of
ACAPA repair. He died in the ﬁrst postoperative day.
Five patients (4.2%) required ECMO postoperatively
and one of them died early (described above), resulting
in a 20% mortality for ECMO patients. Patients with
mitral valve repair/replacement (MVR) at index did not
have increased short-term mortality (0% with MVR vs
2.1% without MVR, p=0.8).
A total of nine (7.5%) patients required early reopera-
tions. Out of these, four had unknown cardiac proce-
dures, two had MVR, one had a right ventricular outﬂow
tract dilation (described above), one had a MVR while
one had a coronary reintervention and a mitral annulo-
plasty (being the only one who also died). All patients
were under 6 months at the time of reoperation.
Long-term results
Survival, freedom from coronary reintervention and
freedom from mitral valve reintervention estimates at
12 years can be seen in ﬁgure 2. No patient died after
1 year of follow-up. The coronary artery reinterventions
were performed in the ﬁrst 2 years of follow-up (median
10.2 months), while the mitral valve reinterventions were
performed in the ﬁrst 5 years of follow-up (median
3.7 months). Three patients (2.9%) had pulmonary
conduit and artery reinterventions: one early right ven-
tricular outﬂow tract balloon dilation after 12 days, a
balloon dilation of the pulmonary branches after
3 months and a pulmonary artery reconstruction after
1.8 years. Freedom from any reintervention (coronary,
mitral or pulmonary) is 87.2% at 12 years, with all reinter-
ventions (early and late) being summarised in ﬁgure 3.
The only risk factor identiﬁed for late mortality was
the need for postoperative ECMO (p<0.001). Identiﬁed
risk factors for coronary reintervention were age under
30 days (p=0.06) and the need for postoperative ECMO
(p=0.02). In terms of mitral valve reintervention, the
only identiﬁed risk factor was age under 30 days
(p=0.002). The need for reinterventions did not
adversely affect the long-term survival.
Of the four patients who required a coronary reinter-
vention two also had a MVR at the same time, account-
ing for 2/8 of all patients with a mitral valve
reintervention. Of the seven patients with a MVR
procedure at index two (28.5%) also had a mitral valve
reintervention. A detailed description of mitral valve
procedures performed at index and during the
follow-up can be seen in ﬁgure 4.
COMMENT
This is, to the best of our knowledge by far the largest
multicentre series presenting results of ACAPA correc-
tion in infants to date. Using information from a
national audit database we report results from a national
population that are both representative and generalis-
able, hence not limited to the results of experienced
centres.
Similarly to previously published, smaller series,8 we
decided to focus on infants, since this is a homogenous
and distinct group. Having the least developed coronary
collaterals, they require urgent treatment after diagnosis
and present with various degrees of heart failure.
Table 2 Associated cardiac malformations and
procedures at index in patients with ACAPA (not including
mitral valve regurgitation and procedures), n=120
Malformations* Procedures
PDA 5 PDA closure 3
VSD 2 VSD closure 2
Pulmonary stenosis 1 Coarctation repair 1
Mitral valve stenosis 1 Pulmonary valve
procedure
1
Coarctation of the aorta 1 Atrial procedure 1
Superior vena cava persisting
to coronary sinus
1
*Atrial septal defects (including patent foramen ovale) and patent
arterial duct presence and correction are only reported to NICOR
if considered clinically significant.
ACAPA, anomalous origin of coronary artery from the pulmonary
artery; NICOR, National Institute for Cardiovascular Outcomes
Research; PDA, patent arterial duct; VSD, ventricular septal
defect.
Figure 2 Long-term results estimates for patients with
anomalous origin of coronary artery from the pulmonary
artery, showing survival, freedom from coronary and mitral
valve reintervention plots. Values shown are 10-year
estimates, obtained using the Kaplan-Meier method. Vertical
axis does not start at 0. Patients at risk are similar for all three
survival functions.
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Mortality risk factors
Early mortality after re-establishment of a dual coronary
artery repair using coronary artery transfer or the tunnel
operation (Takeuchi procedure) ranges between 0 and
23%.2 Direct coronary artery transfer is currently the
most favoured technique after becoming popular
through increasing experience with the arterial switch
operation. The combined early mortality for patients
having coronary transfer or Takeuchi in our series
was 2.5%.
Use of postoperative ECMO was associated with
increased early and late mortality in this study. This may
be related to the critical condition at presentation in
these patients which prompted postoperative support. In
one of the largest series to date, patients who required
postoperative ECMO were more likely to present with a
low ejection fraction.5 Low left ventricle ejection fraction
at presentation was found to be a risk factor for opera-
tive mortality in most series.3 4 9 10 As stated above, we
have not used this parameter in analysis due to limita-
tions in the audit database. The fact that young age at
operation has been associated with operative mortality,
as in previously published results,10 further points to the
conclusion that early presentation in neonates is often
associated with critical heart failure.
Late deaths are rare after restoration of dual coronary
system and ventricular recovery. In our study we had
three deaths after 30 days, all before 1 year of follow-up,
resulting in an actuarial survival of 94% at 10 years,
which is comparable with previously published results.3–5
Figure 3 Flow chart showing
reinterventions by type in patients
with anomalous origin of coronary
artery from the pulmonary artery
patients, divided into early (before
30 days) and late (after 30 days).
Some patients underwent both
early and late reinterventions or
more than one late reintervention.
Figure 4 Flow chart showing
mitral reinterventions by type in
all patients. MV, mitral valve.
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Reinterventions
The largest series to date reported excellent freedom
from reintervention rates in the range of 81–93% at
10 years.3–5 In our study, we also found freedom from all
reinterventions (mitral, coronary and pulmonary) to be
87.2% at 12 years.
Age below 30 days was associated with an increased
risk for coronary and mitral reintervention, while post-
operative ECMO was linked to a higher risk of coronary
reinterventions. Patients presenting in the neonatal
period are more likely to have more severe ischaemia
and mitral regurgitation because they are at the end of
the spectrum of insufﬁcient coronary collateralisation, as
suggested by Azakie et al.5 This is a possible explanation
for the higher risk of coronary and mitral reinterven-
tions in this age group. The higher risk of mitral reinter-
vention may also be related to the technical difﬁculties
posed by repairing the mitral valve at this age.2 ECMO
patients are more likely to have more severe ischaemia
resulting in a poor ventricular function requiring post-
operative support. This could explain the higher risk of
coronary reintervention we identiﬁed in this subgroup.
In our group, two of four patients who required a cor-
onary reintervention also underwent a MVR in the same
operation, accounting for 2/8 of all patients who under-
went MVRs in the follow-up. This naturally suggests that
a failing coronary connection leads to aggravation of the
mitral valve regurgitation. Since all coronary reinterven-
tions in our study occurred during the ﬁrst year of
follow-up, a careful monitoring of myocardial ischaemia
during this time interval is warranted.
The tunnel/intrapulmonary bafﬂing procedure
(Takeuchi operation) has its speciﬁc complications:
supravalvular pulmonary stenosis and bafﬂe leaks.11 In
the present series we had two patients with late supraval-
var pulmonary reinterventions and one patient who
required an early balloon dilation of the pulmonary
conduit.
Limitations
Our study is derived from a national procedure audit
database, thus shares all its limitations. The main down-
side of the NICOR database is its focus on procedural
data, rather than patient-level data, since its primary
objective is to allow for complex national quality index
checks. This leads to a limited number of collected vari-
ables in order to ensure a high-quality index for the key
procedure ﬁelds. Nevertheless, the NICOR curated data-
base is sufﬁciently robust to allow fresh insights into
both adult and congenital procedures.12–14 The main
limitations in this study are the lack of clinical, operative
and echocardiographic data. At the time of the analysis,
CCAD did not differentiate between ALCAPA and
ARCAPA, although considering the particularities of
infants presenting with this anomaly, it is safe to assume
that the majority are indeed patients with ALCAPA. In
our own series of 26 ACAPA repairs performed in a
single centre between 1982 and 2013, 23 patients had
ALCAPA and only three had ARCAPA. Patients with
ARCAPA presented in late adulthood, above the age of
46 years. In addition, we could not differentiate between
the Takeuchi repair and coronary artery transfer in the
national data set, so we were unable to compare the two
procedures.
The lack of echocardiographic data did not allow an
analysis of the LV performance and degree of mitral
valve regurgitation following ALCAPA correction. This
prevented us from drawing any conclusions with regards
to the myocardial recovery and the fate of the mitral
regurgitation after repair. A second study aimed at
extracting clinical, operative and echocardiographic data
is warranted to further characterise these groups.
Finally, we acknowledge the lack of long-term
follow-up in 15% cases.
CONCLUSIONS
These preliminary national results show that early out-
comes are good and medium-term attrition acceptable.
Poor outcomes are correlated with early presentation,
being also linked to the need for postoperative circula-
tory support. Further clinical studies are needed to eluci-
date the best surgical approach in early childhood, the
role and the timing of mitral surgery and the import-
ance of myocardial perfusion tests in the early follow-up.
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